COVID-19 Impact on Terumo Corps Revenue and Operations (Medical Devices)
COVID-19 Impact on Terumo Corps Revenue and Operations (Medical Devices)
Terumo Corp is a medical technology company which manufactures and markets a range of medical devices, is headquartered in Japan, and sells its products in more than 160 countries. Terumo’s product range includes cardiovascular interventional products such as drug eluting stents, PTCA dilation catheters, as well as general disposable hospital equipment and blood management equipment. The report, COVID-19 Impact on Terumo Corps Revenue and Operations (Medical Devices) presents a deep dive analysis into how Terumo Corp is placed to respond to the COVID-19 crisis, by examining its sector performance and competitiveness.
Deep dive analysis into how Terumo Corp is placed to respond to the COVID-19 crisis, by examining its sector performance and competitiveness.
Key Highlights
- The spread of COVID-19 has put a large portion of Terumo’s revenue at risk. In particular, the cardiovascular and general surgery sectors may be at risk due to deferral of non urgent procedures.
- Increase in COVID-19 cases, especially in Europe and the US, have worsened the general outlook of sales.
- Terumo’s offering of devices used to treat COVID-19 patients in hospitals may help reduce the negative impact caused by the pandemic.
Scope
The report provides a comprehensive analysis of the impact of COVID-19 on Terumo Corp -
- It provides insights on Terumo Corps exposure to the regions and businesses impacted by the COVID-19 outbreak.
- It offers an overview of the company’s revenue impact by region and market for 2020 due to the COVID-19 outbreak.
Reasons to Buy
- An overview of how Terumo Corp will be affected by the COVID-19 pandemic.
COVID-19 impact analysis on Terumo - Key Findings
Terumo Key Facts
Geographic spread analysis - COVID-19 vs Terumo’s sales
The impact of COVID-19 on regional GDP per capita levels
Terumo’s exposure: revenues by region and market vs regional impact levels
Terumos : revenue impact by region and market for 2020
Operational reactions from Terumo’s Indications from the US pricing trends
Contact us
Reconstruction Meshes (General Surgery) - Global Market Analysis and Forecast Model (COVID-19 Market Impact)
Reconstruction Meshes (General Surgery) - Global Market Analysis and Forecast Model (COVID-19 Market Impact)Reconstruction Meshes (General Surgery) - Global Market Analysis and Forecast Model (COVID-19 Market Impact) is built to
USD 7500 View ReportDisposable Endoscopes (General Surgery) - Global Market Analysis and Forecast Model (COVID-19 Market Impact)
Disposable Endoscopes (General Surgery) - Global Market Analysis and Forecast Model (COVID-19 Market Impact)Disposable Endoscopes (General Surgery) - Global Market Analysis and Forecast Model (COVID-19 Market Impact) is built to
USD 7500 View ReportCoronavirus Disease 2019 (COVID-19) Impact on Clinical Trials, 2021 Update
Coronavirus Disease 2019 (COVID-19) Impact on Clinical Trials, 2021 UpdateThis 62-page PowerPoint based report gives an important update to the previous year with an expert analysis on how COVID-19 is
USD 1495 View ReportGlobal Peptide Therapeutics Market (2021 Edition) – Analysis By Drug Type (Generic, Innovative), Manufacturing Type (In-House, Outsourced), Application,, By Region, By Country: Market Insights, Covid-19 Impact, Competition and Forecast (2021-2026)
Executive The Global Peptide Therapeutics Market is valued at USD 32.1 Billion in the year 2020. The growth of Peptide Therapeutics is directly associated with drug development. New drug discovery
USD 2400 View ReportFill The Form For Sample Request